Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KOTOBUKIYA, First Half Ordinary Profit Decreases by 51%, Oct-Dec Ordinary Profit Decreases by 8%
7809 KOTOBUKIYA CO.,LTD. 【J-GAAP】
Earnings ReportKOTOBUKIYA CO.,LTD. <7809> [TSE Std] announced its financial results after the market closed on February 14th (15:31). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending June 2025 (July to December) significantly dropped 51.2% from the same period last year to 0.21 billion yen. The progress rate toward the full-year plan of 1.66 billion yen was 12.6%, also falling below the five-year average of 46.7%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the January to June period (2H) is expected to grow 24.3% from the same period last year, reaching 1.45 billion yen.
In the most recent three-month period, from October to December (2Q), the ordinary profit decreased to 0.28 billion yen, a 7.8% decrease compared to the same period last year. The operating profit margin worsened from 8.7% in the same period last year to 6.7%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2022 | 9,824 | 1,695 | 1,623 | 1,121 | 142.2 | 63.8 | Feb 14, 2023 | J-GAAP |
Jul - Dec, 2023 | 7,376 | 466 | 430 | 293 | 37.0 | 26.9 | Feb 14, 2024 | J-GAAP |
Jul - Dec, 2024 | 6,754 | 226 | 210 | 138 | 17.4 | 12.6 | Feb 14, 2025 | J-GAAP |
YoY | -8.4% | -51.5% | -51.2% | -52.9% | -52.8% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2024 Guidance | ー | ー | ー | ー | - | 0 | Aug 14, 2024 | J-GAAP |
Jul - Dec, 2024 Results | 6,754 | 226 | 210 | 138 | 17.4 | 0 | Feb 14, 2025 | J-GAAP |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 9,003 | 1,190 | 1,170 | 810 | 102.2 | 35 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 10,246 | 1,474 | 1,454 | 1,016 | 127.0 | 40 | Feb 14, 2025 | J-GAAP |
YoY | +13.8% | +23.9% | +24.3% | +25.4% | +24.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jun, 2023 | 18,099 | 2,614 | 2,545 | 1,757 | 222.5 | 30 | Aug 14, 2023 | J-GAAP |
Jun, 2024 | 16,379 | 1,656 | 1,600 | 1,103 | 139.1 | 35 | Aug 14, 2024 | J-GAAP |
Jun, 2025 Guidance | 17,000 | 1,700 | 1,664 | 1,154 | 144.2 | 40 | Aug 14, 2024 | J-GAAP |
YoY | +3.8% | +2.7% | +4.0% | +4.6% | +3.6% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 3,904 | 339 | 306 | 212 | 26.7 | 8.7 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 3,253 | 248 | 242 | 166 | 21.0 | 7.6 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 5,750 | 942 | 928 | 644 | 81.2 | 16.4 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 2,968 | -27 | -72 | -53 | -6.8 | -0.9 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 3,786 | 253 | 282 | 191 | 24.1 | 6.7 | Feb 14, 2025 | J-GAAP |
YoY | -3.0% | -25.4% | -7.8% | -9.9% | -9.8% |
Related Articles
Delta-Fly Pharma, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
PARIS MIKI, Oct-Dec (3Q) Ordinary Profit Increases by 26%
Perseus Proteomics, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
FREESIA MACROSS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 17%
CRESTEC, First Half Ordinary Profit Increases by 31%, Oct-Dec Ordinary Profit Increases by 3.0 times
VALTES HOLDINGS, The Current Fiscal Year Ordinary Profit Revised Downward by 13%
Orchestra Holdings, 15% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen
CTI Engineering, 5% Increase in Ordinary Profit for The Current Fiscal Year
VLC HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Loss Narrows
ZUU, Oct-Dec (3Q) Ordinary Profit Decreases by 76%